Switch to:
More From Other Websites
J&J Woos Billionaire Doctors Who Don’t Need Cash in Actelion Bid Dec 06 2016
Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
Sanofi to Explore Counterbid for Actelion Amid J&J Talks Dec 05 2016
Dow Sets Record High as Oil Maintains Momentum Dec 05 2016
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical Dec 05 2016
Stock Futures Rise as Wall Street Shrugs Off Italy Referendum Defeat; Oil Gains Dec 05 2016
J&J's $26 Billion Swiss Drugs Experiment Dec 05 2016
Why Merck’s Immunology Business Matters Now Dec 05 2016
6:00 am Johnson & Johnson announces follow-up results of patients treated with IMBRUVICA for chronic... Dec 05 2016
Novartis CEO plays down prospects for Actelion bid - Blick Dec 04 2016
J&J Plans to Appeal Staggering $1B Judgment Against Hip Implant Dec 02 2016
J&J’s Raised Offer for Actelion Said North of $250 a Share Dec 02 2016
Actelion's silence has hedge funds betting big on J&J deal Dec 02 2016
Actelion's silence has hedge funds betting big on J&J deal Dec 02 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK